Practical and Theoretical Radiotherapy Physics Courses
Course overview
This course provides practical and theoretical education for the support of a modern radiotherapy physics service within radiotherapy.
It is aimed primarily at recently qualified radiotherapy physicists, but should also be invaluable to post-graduate students, researchers, clinical oncologists, engineers, radiographers, manufacturers’ representatives and in fact, anyone needing to deepen or update their understanding of this rapidly evolving field.
The faculty is composed of physicists, clinicians and radiographers, many of whom are internationally renowned for their expertise. Workshops and demonstrations make full use of the facilities of the Radiotherapy and Physics Departments of The Royal Marsden NHS Foundation Trust. The course content is reviewed annually to reflect changes in practice and technology.
Course details
4-8 November 2025: the course in November will be held at our Sutton Site
Course fees
The cost for one week is £800.00. For those wishing to book the complete two weeks, the cost is discounted to £1,350.
External, full-time PhD students with proof of academic registration can book the eight lecture days of both weeks for a total of £700.
For registration details you can email our course secretary.
Contacts
Further details on course content can be obtained from the course organisers:
Tel: +44 (0)20 7808 2506
Fax: +44 (0)20 7808 2522
Tel: +44 (0)20 8661 3475
Fax: +44 (0)20 8643 3812
Latest ICR News
How advances in microscopy are transforming structural biology at the ICR
At The Institute of Cancer Research, London, our ability to visualise the intricate inner workings of cancer is going from strength to strength. Robbie Lockyer spoke with scientists using cutting-edge imaging techniques to uncover how these tools are helping us understand cancer in unprecedented detail.
Dame Stella Rimington, former Chair of the ICR, dies aged 90
Dame Stella Rimington, who served as Chair of the Board of Trustees at The Institute of Cancer Research, London, from 1997 to 2005, died on 3 August 2025.
New MRI scan can spot tiny traces of blood cancer after treatment
Whole-body MRI scans provide powerful insights into treatment effectiveness and long-term outcomes for patients with myeloma, an incurable but treatable blood cancer. Results from the iTIMM study led by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London have shown that whole-body MRI scans (WB-MRI) can detect tiny traces of the disease, known as minimal residual disease (MRD), in the bone marrow after treatment. This can provide a crucial insight into how well patients with multiple myeloma are responding to treatment and whether they might relapse - offering a potential new standard in how this complex blood cancer is assessed.
Small fragments, big impact: discovering the 'shearosomes' that drive cancer's spread
A collaborative study reveals an unexpected way cancer spreads through the body – by shedding tiny, previously unidentified fragments called shearosomes as tumour cells squeeze through narrow blood vessels. Shearosomes appear to actively influence their surroundings, supporting the growth of secondary tumours, offering new insights into how cancer spreads.